Suicidal behavior among Turkish patients with Parkinson’s disease

Suicidal behavior among Turkish patients with Parkinson’s disease

Betul Ozdilek,1 Bulent Kadri Gultekin21Department of Neurology, 2Department of Psychiatry, Erenkoy Mental Health and Neurology Training and Research Hospital, Istanbul, TurkeyObjective: To investigate the predictors of suicidal ideation and attempts among Turkish Parkinson’s disease (PD)...

Full description

Bibliographic Details
Main Authors:	Ozdilek B, Gultekin BK
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-03-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/suicidal-behavior-among-turkish-patients-with-parkinsonrsquos-disease-a16234

Similar Items

Social phobia in Parkinson’s disease: Prevalence and risk factors
by: Gultekin BK, et al.
Published: (2014-05-01)

Serum Leptin Concentrations in Turkish Parkinson’s Disease Population
by: Betul Ozdilek, et al.
Published: (2014-01-01)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
by: Martinez-Martin P, et al.
Published: (2019-04-01)

Parkinson’s disease psychosis
by: Jakel RJ, et al.
Published: (2014-03-01)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
by: Kose Ozlece H, et al.
Published: (2018-07-01)

Patients&rsquo; and caregivers&rsquo; experiences of the impact of Parkinson&rsquo;s disease on health status
by: Horacio Chiong-Rivero, et al.
Published: (2011-03-01)

Voice treatment in Parkinson’s disease: patient perspectives
by: Gillivan-Murphy P, et al.
Published: (2019-07-01)

Parkinson’s disease managing reversible neurodegeneration
by: Hinz M, et al.
Published: (2016-04-01)

Reliability and validity of the Turkish version of king's Parkinson's disease pain scale
by: Ferhan Soyuer, et al.
Published: (2020-01-01)

Driving in Parkinson’s Disease
by: Betül Özdilek, et al.
Published: (2014-09-01)

Spinal versus General Anesthesia for Patients with Parkinson’s Disease
by: Bani Hani DA, et al.
Published: (2020-01-01)

Altered emotional recognition and expression in patients with Parkinson’s disease
by: Jin Y, et al.
Published: (2017-11-01)

Parkinson’s disease-associated melanin steal
by: Hinz M, et al.
Published: (2014-12-01)

Rasagiline in treatment of Parkinson&rsquo;s disease
by: Lakshmi Nayak, et al.
Published: (2008-03-01)

Neuropsychiatric symptoms in untreated Parkinson’s disease
by: Szatmari S, et al.
Published: (2017-03-01)

The role of rasagiline in the treatment of Parkinson’s disease
by: Julie Leegwater-Kim, et al.
Published: (2010-05-01)

Sleep disorders in Parkinson&rsquo;s disease
by: Israt Jahan, et al.
Published: (2009-10-01)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Different protocols for analyzing behavior and adaptability in obstacle crossing in Parkinson’s disease
by: Mollaei N, et al.
Published: (2017-11-01)

Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
by: Berardelli I, et al.
Published: (2018-01-01)

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
by: Zou YM, et al.
Published: (2015-06-01)

Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude
by: Cao Y, et al.
Published: (2021-05-01)

Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
by: Georgescu D, et al.
Published: (2016-11-01)

Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
by: Mao CJ, et al.
Published: (2017-10-01)

Sex-related differences in homebound advanced Parkinson’s disease patients
by: Nwabuobi L, et al.
Published: (2019-07-01)

Prevalence, impact, and management of depression and anxiety in patients with Parkinson’s disease
by: Renfroe JB, et al.
Published: (2016-04-01)

Prevalence of hypersexual behavior in Parkinson&rsquo;s disease patients: Not restricted to males and dopamine agonist use
by: Christine A Cooper, et al.
Published: (2009-03-01)

Current approaches to the treatment of Parkinson&rsquo;s disease
by: Joseph Jankovic, et al.
Published: (2008-09-01)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
by: Holly A Shill, et al.
Published: (2008-12-01)

Advances with microRNAs in Parkinson’s disease research
by: Ma L, et al.
Published: (2013-10-01)

Diagnosis of Parkinson’s disease: progress and future prospects
by: Patel RA, et al.
Published: (2015-07-01)

A review of pulmonary function in Parkinson’s disease
by: O'Callaghan A, et al.
Published: (2018-04-01)

The resurgence of neurotransmitter modulation in Parkinson’s disease with safinamide
by: Müller T
Published: (2015-03-01)

Safinamide: an add-on treatment for managing Parkinson’s disease
by: Müller T
Published: (2018-04-01)

Cognitive deficits in Parkinson’s disease: current perspectives
by: Cosgrove J, et al.
Published: (2018-01-01)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism
by: Skogar O, et al.
Published: (2018-10-01)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
by: Modugno N, et al.
Published: (2020-12-01)